Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
TCA Venture Group Portfolio Company BMI OrganBank Honored with Luis Villalobos Award in Life Sciences
Today 15:15 EDT
Via
PRLog
Exposures
Product Safety
Is Moderna Stock a No-Brainer Buy After a Key FDA Win?
↗
Today 14:35 EDT
Via
The Motley Fool
Tickers
MRNA
Exposures
COVID-19
Product Safety
Penny Stock Vistagen Keeps Regulatory Plans Alive Despite Anxiety Study Miss
↗
Today 13:35 EDT
Via
Benzinga
Exposures
Product Safety
Sarepta Moves Closer To FDA Approval For Duchenne Muscular Dystrophy Drugs
↗
Today 12:44 EDT
Via
Benzinga
Exposures
Product Safety
Why Is Unicycive Therapeutics Stock Falling Tuesday?
↗
Today 11:04 EDT
Via
Benzinga
Exposures
Product Safety
Medline Inc. (NASDAQ: MDLN) Faces Possible Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Today 10:30 EDT
Via
NewMediaWire
Tickers
MDLN
Exposures
Product Safety
Medline Inc. (NASDAQ: MDLN) Faces Possible Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Today 10:30 EDT
Via
TheNewswire.com
Tickers
MDLN
Exposures
Product Safety
Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness
↗
Today 10:17 EDT
Via
Benzinga
Tickers
LLY
Exposures
Product Safety
Currently Approved Drug Could Boost Immunotherapy Against Liver Cancer
Today 10:05 EDT
Via
Investor Brand Network
Tickers
BMWYY
CLDI
Exposures
Product Safety
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
Today 9:35 EDT
Via
Investor Brand Network
Topics
Intellectual Property
Tickers
BEAT
Exposures
Intellectual Property
Product Safety
NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances SPC-15 Intranasal PTSD Program With Device Robustness Study
Today 9:15 EDT
Via
Investor Brand Network
Tickers
SILO
Exposures
Product Safety
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
Today 9:00 EDT
Via
FinancialNewsMedia
Tickers
CMPS
DFTX
GHRS
HELP
JNJ
Exposures
Product Safety
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device
Today 8:30 EDT
Via
Newsfile
Tickers
COCH
Exposures
Product Safety
OS Therapies Provides U.S. Regulatory Update
Today 7:40 EDT
Via
Newsfile
Tickers
ARM
OSTX
Exposures
Product Safety
United States Biosimilar Market Size Projected to Reach USD 33.2 Billion by 2034, Growing at a CAGR of 17.60%
↗
Today 4:51 EDT
Via
Talk Markets
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Joint Statement on Warning to Pharmacists About Diverted HIV Medicines Being Sold on Online Pharmacy-to-Pharmacy Platforms
Today 3:00 EDT
Via
24-7 Press Release
Topics
Economy
Fraud
Tickers
META
Exposures
Legal
Product Safety
Supply Chain
Infectious Disease Diagnostics Market: Size, Trends, and Growth Dynamics
↗
Today 2:10 EDT
Via
Talk Markets
Exposures
Product Safety
Zoetis Inc. (ZTS) Investors: July 27, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
June 29, 2026
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
ZTS
Exposures
Financial
Legal
Product Safety
Zoetis Inc. (ZTS) Investors: July 27, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
June 29, 2026
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
ZTS
Exposures
Financial
Legal
Product Safety
Artivion Seeks To Tap $150 Million US Market Opportunity With FDA Approval
↗
June 29, 2026
Via
Benzinga
Exposures
Product Safety
AbbVie Extends Reach Across Dermatology Markets With Dual Regulatory Wins
↗
June 29, 2026
Via
Benzinga
Exposures
Product Safety
FDA Approval Positions United Therapeutics To Broaden Access To Donor Lungs
↗
June 29, 2026
Via
Benzinga
Exposures
Product Safety
AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026
June 29, 2026
Via
PRLog
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Growing Scientific Evidence Links E-Cigarette Chemicals to Heart Health Risks
June 29, 2026
Via
NewMediaWire
Exposures
Product Safety
Kaplan Fox Reminds Investors of Medline Inc. (NASDAQ: MDLN) to an Investigation of Possible Securities Law Violations
June 29, 2026
Via
TheNewswire.com
Tickers
MDLN
Exposures
Product Safety
Kaplan Fox Reminds Investors of Medline Inc. (NASDAQ: MDLN) to an Investigation of Possible Securities Law Violations
June 29, 2026
Via
NewMediaWire
Tickers
MDLN
Exposures
Product Safety
Larimar Stock Slides 15% Despite FDA Backing Rolling Submission For Rare Disease Drug
↗
June 29, 2026
Via
Benzinga
Exposures
Product Safety
FDA Manufacturing Issues Delay Lantheus' Tumor Imaging Kit
↗
June 29, 2026
Via
Benzinga
Exposures
Product Safety
NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Enrolls First Patient in Phase 2 Depression Trial
June 29, 2026
Via
Investor Brand Network
Tickers
TNXP
Exposures
COVID-19
Product Safety
Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease
↗
June 29, 2026
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.